Placebo control, double blind, crossover clinical pharmacological study to evaluate a sedative effect after histamine H1 receptor antagonist diphenhydroamine (Drewell®) administration by using saccadic eye movement analyzing system in healthy Japanese elderly male volunteers. - Clinical pharmacological study to evaluate a sedative effect of histamine H1 receptor antagonist diphenhyroamine (Drewell®) in elderly male.

Showa University School of Medicine Second department of Pharmacology0 个研究点目标入组 8 人开始时间: 2006年1月31日最近更新: 2023年10月17日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 8

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

The pharmacokinetics parameters of diphenhydramine in this study were similar to those reported previously. The values of Saccadic Peak Velocity (SPV) and also Inaccuracy (IAC), as a subjective parameter of sedative effect in the Drewell group from 90 minutes to 180 minutes after drug administration declined significantly (p<0.05 paired t-test followed by repeated measures ANOVA). There was no significant difference in Latency and Visual Analogue Scale (VAS), as a subjective parameter for sedation. Jpn. J Clin. Pharmacol. Ther.,37(5), p283-290, 2006

研究设计

研究类型: Interventional

入排标准

年龄范围: 65years-old 至 ot applicable（—）
性别: Male

入选标准

未提供

排除标准

•1.Any clinically significant history of drug abuse, alcoholic abuse, heart, liver, kidney, lung, and blood disease etc. thought to be not eligible to participate in the study 2.Subjects known to treated with medicine which has a sedative effect or an antihistaminic agents 3.Past history and/or present illness of glaucoma 4. Past history and/or present illness of prostatic hypertrophy or dysuria 5.Subjects who can not abstaine from smoking during study period 6.Any drug allergy history 7.Subjects who is using excessive alcohol regularly (cannot keep abstinence for study period) 8.Perticipation in any clinical trial within 3 months 9.Donation of more than 200mL blood within 3 months 10.Any use of drugs in the 1 weeks prior to study drug administration 11. Person who cannot do appropriate measurement according to the instruction at training session 12.Subjects who, in the opinion of the investigator, are not likely to participate in the study for any reason

研究者

发起方

Showa University School of Medicine Second department of Pharmacology

相似试验

已完成

不适用

Placebo control, double blind, crossover clinical pharmacological study to evaluate a sedative effect after histamine H1 receptor antagonist diphenhydramine administration by using saccadic eye movement analyzing system and visual analogue scale (VAS) in healthy Japanese male volunteersJapanese healthy male volunteers

JPRN-C000000003Showa University School of Medicine Second department of Pharmacology8

已完成

1 期

Bioequivalence Between Two Oral Formulations of Diphenhydramine HydrochlorideNasal Congestion

NCT00662337Johnson & Johnson Consumer and Personal Products Worldwide36

已完成

1 期

Study to Evaluate Diphenhydramine in Children and AdolescentsAllergic Rhinitis

NCT00762749Johnson & Johnson Consumer and Personal Products Worldwide36

已完成

1 期

A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male SubjectsHealthy Volunteers

NCT03776240Prestige Biopharma Limited105

已完成

1 期

Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®Healthy Subjects

NCT04027803Biocad78